{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:14:23Z","timestamp":1778886863671,"version":"3.51.4"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11102-024-01466-0","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T09:14:48Z","timestamp":1731575688000},"page":"945-954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cushing\u2019s syndrome and COVID-19"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0570-749X","authenticated-orcid":false,"given":"Amina","family":"Attia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2551-3008","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Bertherat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"1466_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41577-021-00522-1","volume":"21","author":"T Carvalho","year":"2021","unstructured":"Carvalho T, Krammer F, Iwasaki A (2021) The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol 21:245\u2013256. https:\/\/doi.org\/10.1038\/s41577-021-00522-1","journal-title":"Nat Rev Immunol"},{"key":"1466_CR2","unstructured":"World Health Organization (2024) WHO COVID-19 dashboard. In: WHO. https:\/\/data.who.int\/dashboards\/covid19\/. Accessed 10 Mar 2024"},{"key":"1466_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","volume":"94","author":"J Yang","year":"2020","unstructured":"Yang J, Zheng Y, Gou X et al (2020) Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 94:91\u201395. https:\/\/doi.org\/10.1016\/j.ijid.2020.03.017","journal-title":"Int J Infect Dis"},{"key":"1466_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.46234\/ccdcw2020.032","volume":"2","author":"C Cdc Weekly","year":"2020","unstructured":"Cdc Weekly C, The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) The epidemiological characteristics of an outbreak of 2019 Novel Coronavirus diseases (COVID-19) \u2014 China, 2020. China CDC Wkly 2:113\u2013122. https:\/\/doi.org\/10.46234\/ccdcw2020.032","journal-title":"China CDC Wkly"},{"key":"1466_CR5","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC et al (2020) Pathophysiology, transmission, diagnosis, and treatment of Coronavirus disease 2019 (COVID-19): a review. JAMA 324:782. https:\/\/doi.org\/10.1001\/jama.2020.12839","journal-title":"JAMA"},{"key":"1466_CR6","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W Guan","year":"2020","unstructured":"Guan W, Ni Z, Hu Y et al (2020) Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 382:1708\u20131720. https:\/\/doi.org\/10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"1466_CR7","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.tem.2020.04.004","volume":"31","author":"V Hasenmajer","year":"2020","unstructured":"Hasenmajer V, Sbardella E, Sciarra F et al (2020) The immune system in Cushing\u2019s syndrome. Trends Endocrinol Metabolism 31:655\u2013669. https:\/\/doi.org\/10.1016\/j.tem.2020.04.004","journal-title":"Trends Endocrinol Metabolism"},{"key":"1466_CR8","doi-asserted-by":"publisher","unstructured":"Feelders R, Sharma S, Nieman L (2015) Cushing\u2019s syndrome: epidemiology and developments in disease management. CLEP 281. https:\/\/doi.org\/10.2147\/CLEP.S44336","DOI":"10.2147\/CLEP.S44336"},{"key":"1466_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho AE, Chapman KE (2011) The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335:2\u201313. https:\/\/doi.org\/10.1016\/j.mce.2010.04.005","journal-title":"Mol Cell Endocrinol"},{"key":"1466_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.beem.2009.06.001","volume":"23","author":"X Bertagna","year":"2009","unstructured":"Bertagna X, Guignat L, Groussin L, Bertherat J (2009) Cushing\u2019s disease. Best Pract Res Clin Endocrinol Metab 23:607\u2013623. https:\/\/doi.org\/10.1016\/j.beem.2009.06.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1466_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000314272","volume":"92","author":"P Chanson","year":"2010","unstructured":"Chanson P, Salenave S (2010) Metabolic syndrome in Cushing\u2019s syndrome. Neuroendocrinology 92:96\u2013101. https:\/\/doi.org\/10.1159\/000314272","journal-title":"Neuroendocrinology"},{"key":"1466_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1046\/j.1563-2571.2000.00106.x","volume":"27","author":"H Biering","year":"2000","unstructured":"Biering H, Knappe G, Gerl H, Lochs H (2000) Diabetes-haufigkeit bei akromegalie und cushing-syndrom. Acta Med Austriaca 27:27\u201331. https:\/\/doi.org\/10.1046\/j.1563-2571.2000.00106.x","journal-title":"Acta Med Austriaca"},{"key":"1466_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.tem.2011.09.001","volume":"22","author":"G Mazziotti","year":"2011","unstructured":"Mazziotti G, Gazzaruso C, Giustina A (2011) Diabetes in Cushing syndrome: basic and clinical aspects. Trends Endocrinol Metabolism 22:499\u2013506. https:\/\/doi.org\/10.1016\/j.tem.2011.09.001","journal-title":"Trends Endocrinol Metabolism"},{"key":"1466_CR14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello R, Isidori AM, De Martino MC et al (2016) Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabetes Endocrinol 4:611\u2013629. https:\/\/doi.org\/10.1016\/S2213-8587(16)00086-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1466_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1530\/EJE-13-0754","volume":"170","author":"C Giordano","year":"2014","unstructured":"Giordano C, Guarnotta V, Pivonello R et al (2014) Is diabetes in Cushing\u2019s syndrome only a consequence of hypercortisolism? Eur J Endocrinol 170:311\u2013319. https:\/\/doi.org\/10.1530\/EJE-13-0754","journal-title":"Eur J Endocrinol"},{"key":"1466_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1210\/er.2016-1105","volume":"38","author":"C Scaroni","year":"2017","unstructured":"Scaroni C, Zilio M, Foti M, Boscaro M (2017) Glucose metabolism abnormalities in Cushing syndrome: from molecular basis to clinical management. Endocr Rev 38:189\u2013219. https:\/\/doi.org\/10.1210\/er.2016-1105","journal-title":"Endocr Rev"},{"key":"1466_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","volume":"61","author":"T Mancini","year":"2004","unstructured":"Mancini T, Kola B, Mantero F et al (2004) High cardiovascular risk in patients with Cushing\u2019s syndrome according to 1999 WHO\/ISH guidelines. Clin Endocrinol 61:768\u2013777. https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02168.x","journal-title":"Clin Endocrinol"},{"key":"1466_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4939-2895-8_5","volume-title":"Glucocorticoid signaling","author":"T Kuo","year":"2015","unstructured":"Kuo T, McQueen A, Chen T-C, Wang J-C (2015) Regulation of glucose homeostasis by glucocorticoids. In: Wang J-C, Harris C (eds) Glucocorticoid signaling. Springer New York, New York, NY, pp 99\u2013126"},{"key":"1466_CR19","doi-asserted-by":"publisher","first-page":"e220416","DOI":"10.1530\/EC-22-0416","volume":"12","author":"HF Nowotny","year":"2023","unstructured":"Nowotny HF, Bryce J, Ali SR et al (2023) Outcome of COVID-19 infections in patients with adrenal insufficiency and excess. Endocr Connections 12:e220416. https:\/\/doi.org\/10.1530\/EC-22-0416","journal-title":"Endocr Connections"},{"key":"1466_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.beem.2006.07.006","volume":"20","author":"MA Magiakou","year":"2006","unstructured":"Magiakou MA, Smyrnaki P, Chrousos GP (2006) Hypertension in Cushing\u2019s syndrome. Best Pract Res Clin Endocrinol Metab 20:467\u2013482. https:\/\/doi.org\/10.1016\/j.beem.2006.07.006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1466_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000314315","volume":"92","author":"MV Cicala","year":"2010","unstructured":"Cicala MV, Mantero F (2010) Hypertension in Cushing\u2019s syndrome: from pathogenesis to treatment. Neuroendocrinology 92:44\u201349. https:\/\/doi.org\/10.1159\/000314315","journal-title":"Neuroendocrinology"},{"key":"1466_CR22","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1530\/EJE-15-0308","volume":"173","author":"AM Isidori","year":"2015","unstructured":"Isidori AM, Minnetti M, Sbardella E et al (2015) MECHANISMS IN ENDOCRINOLOGY: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect. Eur J Endocrinol 173:R101\u2013R113. https:\/\/doi.org\/10.1530\/EJE-15-0308","journal-title":"Eur J Endocrinol"},{"key":"1466_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s12020-015-0665-z","volume":"52","author":"M Zilio","year":"2016","unstructured":"Zilio M, Mazzai L, Sartori MT et al (2016) A venous thromboembolism risk assessment model for patients with Cushing\u2019s syndrome. Endocrine 52:322\u2013332. https:\/\/doi.org\/10.1007\/s12020-015-0665-z","journal-title":"Endocrine"},{"key":"1466_CR24","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/MED.0000000000000630","volume":"28","author":"C Capatina","year":"2021","unstructured":"Capatina C, Fleseriu M (2021) Thromboembolic disease in hypercortisolism. Curr Opin Endocrinol Diabetes Obes 28:330\u2013336. https:\/\/doi.org\/10.1097\/MED.0000000000000630","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1466_CR25","doi-asserted-by":"publisher","first-page":"711612","DOI":"10.3389\/fendo.2021.711612","volume":"12","author":"A Berli\u0144ska","year":"2021","unstructured":"Berli\u0144ska A, \u015awi\u0105tkowska-Stodulska R, Sworczak K (2021) Old problem, new concerns: hypercortisolemia in the time of COVID-19. Front Endocrinol 12:711612. https:\/\/doi.org\/10.3389\/fendo.2021.711612","journal-title":"Front Endocrinol"},{"key":"1466_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12020-021-02674-5","volume":"72","author":"Z Belaya","year":"2021","unstructured":"Belaya Z, Golounina O, Melnichenko G et al (2021) Clinical course and outcome of patients with ACTH-dependent Cushing\u2019s syndrome infected with novel coronavirus disease-19 (COVID-19): case presentations. Endocrine 72:12\u201319. https:\/\/doi.org\/10.1007\/s12020-021-02674-5","journal-title":"Endocrine"},{"key":"1466_CR27","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/S2213-8587(20)30215-1","volume":"8","author":"R Pivonello","year":"2020","unstructured":"Pivonello R, Ferrigno R, Isidori AM et al (2020) COVID-19 and Cushing\u2019s syndrome: recommendations for a special population with endogenous glucocorticoid excess. Lancet Diabetes Endocrinol 8:654\u2013656. https:\/\/doi.org\/10.1016\/S2213-8587(20)30215-1","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1466_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1507\/endocrj.EJ20-0613","volume":"68","author":"A Yuno","year":"2021","unstructured":"Yuno A, Kenmotsu Y, Takahashi Y et al (2021) Successful management of a patient with active Cushing\u2019s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia. Endocr J 68:477\u2013484. https:\/\/doi.org\/10.1507\/endocrj.EJ20-0613","journal-title":"Endocr J"},{"key":"1466_CR29","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/BF03343903","volume":"24","author":"C Blanco","year":"2001","unstructured":"Blanco C, Marazuela M, Flores J, Alvarez J (2001) Severe respiratory failure secondary to Cushing\u2019s myopathy. J Endocrinol Invest 24:618\u2013621. https:\/\/doi.org\/10.1007\/BF03343903","journal-title":"J Endocrinol Invest"},{"key":"1466_CR30","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1210\/jc.2003-030871","volume":"88","author":"G Arnaldi","year":"2003","unstructured":"Arnaldi G, Angeli A, Atkinson AB et al (2003) Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement. J Clin Endocrinol Metabolism 88:5593\u20135602. https:\/\/doi.org\/10.1210\/jc.2003-030871","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1466_CR31","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/jc.2012-3582","volume":"98","author":"OM Dekkers","year":"2013","unstructured":"Dekkers OM, Horv\u00e1th-Puh\u00f3 E, J\u00f8rgensen JOL et al (2013) Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study. J Clin Endocrinol Metabolism 98:2277\u20132284. https:\/\/doi.org\/10.1210\/jc.2012-3582","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1466_CR32","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s40618-020-01419-x","volume":"44","author":"AL Serban","year":"2021","unstructured":"Serban AL, Ferrante E, Carosi G et al (2021) COVID-19 in Cushing disease: experience of a single tertiary centre in Lombardy. J Endocrinol Invest 44:1335\u20131336. https:\/\/doi.org\/10.1007\/s40618-020-01419-x","journal-title":"J Endocrinol Invest"},{"key":"1466_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11154-021-09670-0","volume":"23","author":"F Vogel","year":"2022","unstructured":"Vogel F, Reincke M (2022) Endocrine risk factors for COVID-19: endogenous and exogenous glucocorticoid excess. Rev Endocr Metab Disord 23:233\u2013250. https:\/\/doi.org\/10.1007\/s11154-021-09670-0","journal-title":"Rev Endocr Metab Disord"},{"key":"1466_CR34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1530\/EJE-19-0464","volume":"181","author":"E Valassi","year":"2019","unstructured":"Valassi E, Tabarin A, Brue T et al (2019) High mortality within 90 days of diagnosis in patients with Cushing\u2019s syndrome: results from the ERCUSYN registry. Eur J Endocrinol 181:461\u2013472. https:\/\/doi.org\/10.1530\/EJE-19-0464","journal-title":"Eur J Endocrinol"},{"key":"1466_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-023-03411-w","volume":"82","author":"A Cozzolino","year":"2023","unstructured":"Cozzolino A, Hasenmajer V, Newell-Price J, Isidori AM (2023) COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disorders. Endocrine 82:1\u201314. https:\/\/doi.org\/10.1007\/s12020-023-03411-w","journal-title":"Endocrine"},{"key":"1466_CR36","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s40618-023-02016-4","volume":"46","author":"M Ragonese","year":"2023","unstructured":"Ragonese M, Giuffrida G, Alessi Y et al (2023) Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing\u2019s disease: a monocentric experience in Southern Italy. J Endocrinol Invest 46:1711\u20131715. https:\/\/doi.org\/10.1007\/s40618-023-02016-4","journal-title":"J Endocrinol Invest"},{"key":"1466_CR37","doi-asserted-by":"publisher","first-page":"E680","DOI":"10.1503\/cmaj.190178","volume":"191","author":"J Wu","year":"2019","unstructured":"Wu J, Keeley A, Mallen C et al (2019) Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England. CMAJ 191:E680\u2013E688. https:\/\/doi.org\/10.1503\/cmaj.190178","journal-title":"CMAJ"},{"key":"1466_CR38","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1136\/annrheumdis-2011-200702","volume":"71","author":"WG Dixon","year":"2012","unstructured":"Dixon WG, Abrahamowicz M, Beauchamp M-E et al (2012) Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis 71:1128\u20131133. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200702","journal-title":"Ann Rheum Dis"},{"key":"1466_CR39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.mayocpiqo.2018.01.005","volume":"2","author":"TT Sytsma","year":"2018","unstructured":"Sytsma TT, Greenlund LK, Greenlund LS (2018) Joint corticosteroid injection associated with increased influenza risk. Mayo Clin Proc Innov Qual Outcomes 2:194\u2013198. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2018.01.005","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"1466_CR40","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13075-020-02395-6","volume":"22","author":"EG Favalli","year":"2020","unstructured":"Favalli EG, Bugatti S, Klersy C et al (2020) Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis. Arthritis Res Ther 22:290. https:\/\/doi.org\/10.1186\/s13075-020-02395-6","journal-title":"Arthritis Res Ther"},{"key":"1466_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/cid\/ciab407","volume":"74","author":"KC Fitzgerald","year":"2022","unstructured":"Fitzgerald KC, Mecoli CA, Douglas M et al (2022) Risk factors for infection and health impacts of the Coronavirus disease 2019 (COVID-19) pandemic in people with autoimmune diseases. Clin Infect Dis 74:427\u2013436. https:\/\/doi.org\/10.1093\/cid\/ciab407","journal-title":"Clin Infect Dis"},{"key":"1466_CR42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/annrheumdis-2020-218946","volume":"80","author":"S Akiyama","year":"2021","unstructured":"Akiyama S, Hamdeh S, Micic D, Sakuraba A (2021) Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis 80:384\u2013391. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218946","journal-title":"Ann Rheum Dis"},{"key":"1466_CR43","doi-asserted-by":"publisher","first-page":"583260","DOI":"10.3389\/fphar.2020.583260","volume":"11","author":"N Soldevila-Domenech","year":"2020","unstructured":"Soldevila-Domenech N, T\u00edo L, Llorente-Onaindia J et al (2020) COVID-19 incidence in patients with immunomediated inflammatory diseases: influence of immunosuppressant treatments. Front Pharmacol 11:583260. https:\/\/doi.org\/10.3389\/fphar.2020.583260","journal-title":"Front Pharmacol"},{"key":"1466_CR44","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.idc.2007.06.001","volume":"21","author":"GG Fareau","year":"2007","unstructured":"Fareau GG, Vassilopoulou-Sellin R (2007) Hypercortisolemia and infection. Infect Dis Clin North Am 21:639\u2013657, viii. https:\/\/doi.org\/10.1016\/j.idc.2007.06.001","journal-title":"Infect Dis Clin North Am"},{"key":"1466_CR45","doi-asserted-by":"publisher","first-page":"e001464","DOI":"10.1136\/rmdopen-2020-001464","volume":"7","author":"R Hasseli","year":"2021","unstructured":"Hasseli R, Mueller-Ladner U, Hoyer BF et al (2021) Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases. RMD Open 7:e001464. https:\/\/doi.org\/10.1136\/rmdopen-2020-001464","journal-title":"RMD Open"},{"key":"1466_CR46","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","volume":"79","author":"M Gianfrancesco","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S et al (2020) Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry. Ann Rheum Dis 79:859\u2013866. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217871","journal-title":"Ann Rheum Dis"},{"key":"1466_CR47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJMc2009567","volume":"383","author":"R Haberman","year":"2020","unstructured":"Haberman R, Axelrad J, Chen A et al (2020) Covid-19 in immune-mediated inflammatory diseases - case series from New York. N Engl J Med 383:85\u201388. https:\/\/doi.org\/10.1056\/NEJMc2009567","journal-title":"N Engl J Med"},{"key":"1466_CR48","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/art.41728","volume":"73","author":"MA Rutherford","year":"2021","unstructured":"Rutherford MA, Scott J, Karabayas M et al (2021) Risk factors for severe outcomes in patients with systemic vasculitis and COVID-19: a binational, registry-based cohort study. Arthritis Rheumatol 73:1713\u20131719. https:\/\/doi.org\/10.1002\/art.41728","journal-title":"Arthritis Rheumatol"},{"key":"1466_CR49","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","volume":"159","author":"EJ Brenner","year":"2020","unstructured":"Brenner EJ, Ungaro RC, Gearry RB et al (2020) Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology 159:481\u2013491e3. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.032","journal-title":"Gastroenterology"},{"key":"1466_CR50","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1136\/annrheumdis-2020-218296","volume":"79","author":"JL Pablos","year":"2020","unstructured":"Pablos JL, Galindo M, Carmona L et al (2020) Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Ann Rheum Dis 79:1544\u20131549. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218296","journal-title":"Ann Rheum Dis"},{"key":"1466_CR51","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/pr.2017.278","volume":"83","author":"C Tatsi","year":"2018","unstructured":"Tatsi C, Boden R, Sinaii N et al (2018) Decreased lymphocytes and increased risk for infection are common in endogenous pediatric Cushing syndrome. Pediatr Res 83:431\u2013437. https:\/\/doi.org\/10.1038\/pr.2017.278","journal-title":"Pediatr Res"},{"key":"1466_CR52","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S2213-8587(20)30216-3","volume":"8","author":"T Tan","year":"2020","unstructured":"Tan T, Khoo B, Mills EG et al (2020) Association between high serum total cortisol concentrations and mortality from COVID-19. Lancet Diabetes Endocrinol 8:659\u2013660. https:\/\/doi.org\/10.1016\/S2213-8587(20)30216-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1466_CR53","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1055\/a-1172-1352","volume":"52","author":"S Shekhar","year":"2020","unstructured":"Shekhar S, Wurth R, Kamilaris CDC et al (2020) Endocrine conditions and COVID-19. Horm Metab Res 52:471\u2013484. https:\/\/doi.org\/10.1055\/a-1172-1352","journal-title":"Horm Metab Res"},{"key":"1466_CR54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejim.2020.04.043","volume":"76","author":"PR Martins-Filho","year":"2020","unstructured":"Martins-Filho PR, Tavares CSS, Santos VS (2020) Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Intern Med 76:97\u201399. https:\/\/doi.org\/10.1016\/j.ejim.2020.04.043","journal-title":"Eur J Intern Med"},{"key":"1466_CR55","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-20-0352","volume":"183","author":"J Newell-Price","year":"2020","unstructured":"Newell-Price J, Nieman LK, Reincke M, Tabarin A (2020) ENDOCRINOLOGY IN THE TIME OF COVID-19: management of Cushing\u2019s syndrome. Eur J Endocrinol 183:G1\u2013G7. https:\/\/doi.org\/10.1530\/EJE-20-0352","journal-title":"Eur J Endocrinol"},{"key":"1466_CR56","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/postgradmedj-2020-137742","volume":"96","author":"R Pal","year":"2020","unstructured":"Pal R, Bhadada SK (2020) COVID-19 and non-communicable diseases. Postgrad Med J 96:429\u2013430. https:\/\/doi.org\/10.1136\/postgradmedj-2020-137742","journal-title":"Postgrad Med J"},{"key":"1466_CR57","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4158\/EP-2020-0308","volume":"26","author":"KCJ Yuen","year":"2020","unstructured":"Yuen KCJ, Blevins LS, Findling JW (2020) Important management considerations in patients with pituitary disorders during the time of the Covid-19 pandemic. Endocr Pract 26:915\u2013922. https:\/\/doi.org\/10.4158\/EP-2020-0308","journal-title":"Endocr Pract"},{"key":"1466_CR58","doi-asserted-by":"publisher","unstructured":"Richardson S, Hirsch JS, Narasimhan M et al (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. https:\/\/doi.org\/10.1001\/jama.2020.6775. JAMA 323:2052","DOI":"10.1001\/jama.2020.6775"},{"key":"1466_CR59","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"1466_CR60","doi-asserted-by":"publisher","first-page":"100158","DOI":"10.1016\/j.lanepe.2021.100158","volume":"8","author":"L Semenzato","year":"2021","unstructured":"Semenzato L, Botton J, Drouin J et al (2021) Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people. Lancet Reg Health - Europe 8:100158. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100158","journal-title":"Lancet Reg Health - Europe"},{"key":"1466_CR61","doi-asserted-by":"publisher","first-page":"108132","DOI":"10.1016\/j.diabres.2020.108132","volume":"162","author":"R Pal","year":"2020","unstructured":"Pal R, Bhansali A (2020) COVID-19, diabetes mellitus and ACE2: the conundrum. Diabetes Res Clin Pract 162:108132. https:\/\/doi.org\/10.1016\/j.diabres.2020.108132","journal-title":"Diabetes Res Clin Pract"},{"key":"1466_CR62","doi-asserted-by":"publisher","first-page":"e3319","DOI":"10.1002\/dmrr.3319","volume":"36","author":"W Guo","year":"2020","unstructured":"Guo W, Li M, Dong Y et al (2020) Diabetes is a risk factor for the progression and prognosis of COVID -19. Diabetes Metabolism Res 36:e3319. https:\/\/doi.org\/10.1002\/dmrr.3319","journal-title":"Diabetes Metabolism Res"},{"key":"1466_CR63","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.2337\/dc20-1380","volume":"43","author":"A Coppelli","year":"2020","unstructured":"Coppelli A, Giannarelli R, Aragona M et al (2020) Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for COVID-19: the Pisa COVID-19 study. Diabetes Care 43:2345\u20132348. https:\/\/doi.org\/10.2337\/dc20-1380","journal-title":"Diabetes Care"},{"key":"1466_CR64","doi-asserted-by":"publisher","first-page":"e33213321","DOI":"10.1002\/dmrr.3321","volume":"36","author":"E Maddaloni","year":"2020","unstructured":"Maddaloni E, Buzzetti R (2020) Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metabolism Res 36:e33213321. https:\/\/doi.org\/10.1002\/dmrr.3321","journal-title":"Diabetes Metabolism Res"},{"key":"1466_CR65","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.2337\/dc20-1340","volume":"43","author":"M Mirani","year":"2020","unstructured":"Mirani M, Favacchio G, Carrone F et al (2020) Impact of comorbidities and glycemia at admission and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes with COVID-19: a case series from an academic hospital in Lombardy, Italy. Diabetes Care 43:3042\u20133049. https:\/\/doi.org\/10.2337\/dc20-1340","journal-title":"Diabetes Care"},{"key":"1466_CR66","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","volume":"23","author":"JK Yang","year":"2006","unstructured":"Yang JK, Feng Y, Yuan MY et al (2006) Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med 23:623\u2013628. https:\/\/doi.org\/10.1111\/j.1464-5491.2006.01861.x","journal-title":"Diabet Med"},{"key":"1466_CR67","doi-asserted-by":"publisher","first-page":"154378","DOI":"10.1016\/j.metabol.2020.154378","volume":"113","author":"Y Huang","year":"2020","unstructured":"Huang Y, Lu Y, Huang Y-M et al (2020) Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabolism 113:154378. https:\/\/doi.org\/10.1016\/j.metabol.2020.154378","journal-title":"Metabolism"},{"key":"1466_CR68","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/oby.22831","volume":"28","author":"A Simonnet","year":"2020","unstructured":"Simonnet A, Chetboun M, Poissy j et al (2020) high prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (sars\u2010cov\u20102) requiring Invasive Mechanical Ventilation. Obesity 28:1195\u20131199. https:\/\/doi.org\/10.1002\/oby.22831","journal-title":"Obesity"},{"key":"1466_CR69","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3760\/cma.j.cn112148-20200220-00105","volume":"48","author":"YD Peng","year":"2020","unstructured":"Peng YD, Meng K, Guan HQ et al (2020) Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV. Zhonghua Xin xue guan bing za zhi 48:450\u2013455. https:\/\/doi.org\/10.3760\/cma.j.cn112148-20200220-00105","journal-title":"Zhonghua Xin xue guan bing za zhi"},{"key":"1466_CR70","doi-asserted-by":"publisher","first-page":"154440","DOI":"10.1016\/j.metabol.2020.154440","volume":"115","author":"G Favre","year":"2021","unstructured":"Favre G, Legueult K, Pradier C et al (2021) Visceral fat is associated to the severity of COVID-19. Metabolism 115:154440. https:\/\/doi.org\/10.1016\/j.metabol.2020.154440","journal-title":"Metabolism"},{"key":"1466_CR71","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jiac.2020.10.013","volume":"27","author":"Y Iijima","year":"2021","unstructured":"Iijima Y, Okamoto T, Shirai T et al (2021) MuLBSTA score is a useful tool for predicting COVID-19 disease behavior. J Infect Chemother 27:284\u2013290. https:\/\/doi.org\/10.1016\/j.jiac.2020.10.013","journal-title":"J Infect Chemother"},{"key":"1466_CR72","doi-asserted-by":"publisher","first-page":"e220313","DOI":"10.20945\/2359-4292-2022-0313","volume":"68","author":"BMG Mascarenhas-Nakano","year":"2024","unstructured":"Mascarenhas-Nakano BMG, Correa-Silva SR, Fracacio SMR et al (2024) The risk of COVID-19 in Cushing\u2019s disease is independently related to disease activity (hypercortisolism) and obesity. Arch Endocrinol Metab 68:e220313. https:\/\/doi.org\/10.20945\/2359-4292-2022-0313","journal-title":"Arch Endocrinol Metab"},{"key":"1466_CR73","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","volume":"221","author":"F Wang","year":"2020","unstructured":"Wang F, Nie J, Wang H et al (2020) Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis 221:1762\u20131769. https:\/\/doi.org\/10.1093\/infdis\/jiaa150","journal-title":"J Infect Dis"},{"key":"1466_CR74","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s11102-013-0522-0","volume":"17","author":"H Masri-Iraqi","year":"2014","unstructured":"Masri-Iraqi H, Robenshtok E, Tzvetov G et al (2014) Elevated white blood cell counts in Cushing\u2019s disease: association with hypercortisolism. Pituitary 17:436\u2013440. https:\/\/doi.org\/10.1007\/s11102-013-0522-0","journal-title":"Pituitary"},{"key":"1466_CR75","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1210\/en.2013-1473","volume":"155","author":"AL Gruver-Yates","year":"2014","unstructured":"Gruver-Yates AL, Quinn MA, Cidlowski JA (2014) Analysis of glucocorticoid receptors and their apoptotic response to dexamethasone in male murine B cells during development. Endocrinology 155:463\u2013474. https:\/\/doi.org\/10.1210\/en.2013-1473","journal-title":"Endocrinology"},{"key":"1466_CR76","doi-asserted-by":"publisher","first-page":"2912763","DOI":"10.1155\/2017\/2912763","volume":"2017","author":"G Aranda","year":"2017","unstructured":"Aranda G, Lopez C, Fernandez-Ruiz R et al (2017) Circulatory Immune cells in Cushing syndrome: bystanders or active contributors to atherometabolic injury? A study of adhesion and activation of cell surface markers. Int J Endocrinol 2017:2912763. https:\/\/doi.org\/10.1155\/2017\/2912763","journal-title":"Int J Endocrinol"},{"key":"1466_CR77","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3389\/fimmu.2019.01744","volume":"10","author":"C Strehl","year":"2019","unstructured":"Strehl C, Ehlers L, Gaber T, Buttgereit F (2019) Glucocorticoids\u2014all-rounders tackling the versatile players of the immune system. Front Immunol 10:1744. https:\/\/doi.org\/10.3389\/fimmu.2019.01744","journal-title":"Front Immunol"},{"key":"1466_CR78","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S1081-1206(10)61380-4","volume":"97","author":"ME Fedor","year":"2006","unstructured":"Fedor ME, Rubinstein A (2006) Effects of long-term low-dose corticosteroid therapy on humoral immunity. Ann Allergy Asthma Immunol 97:113\u2013116. https:\/\/doi.org\/10.1016\/S1081-1206(10)61380-4","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1466_CR79","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.dsx.2020.12.035","volume":"15","author":"R Pal","year":"2021","unstructured":"Pal R, Sachdeva N, Mukherjee S et al (2021) Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: a preliminary report. Diabetes Metabolic Syndrome: Clin Res Reviews 15:193\u2013196. https:\/\/doi.org\/10.1016\/j.dsx.2020.12.035","journal-title":"Diabetes Metabolic Syndrome: Clin Res Reviews"},{"key":"1466_CR80","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.trsl.2013.07.005","volume":"163","author":"PJ Martinez","year":"2014","unstructured":"Martinez PJ, Mathews C, Actor JK et al (2014) Impaired CD4 + and T-helper 17 cell memory response to streptococcus pneumoniae is associated with elevated glucose and percent glycated hemoglobin A1c in Mexican Americans with type 2 diabetes mellitus. Translational Res 163:53\u201363. https:\/\/doi.org\/10.1016\/j.trsl.2013.07.005","journal-title":"Translational Res"},{"key":"1466_CR81","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1600-065X.1988.tb00778.x","volume":"106","author":"SK Pierce","year":"1988","unstructured":"Pierce SK, Morris JF, Grusby MJ et al (1988) Antigen-presenting function of B lymphocytes. Immunol Rev 106:149\u2013180. https:\/\/doi.org\/10.1111\/j.1600-065X.1988.tb00778.x","journal-title":"Immunol Rev"},{"key":"1466_CR82","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pcd.2020.08.002","volume":"15","author":"R Pal","year":"2021","unstructured":"Pal R, Banerjee M (2021) Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19? Prim Care Diabetes 15:18\u201320. https:\/\/doi.org\/10.1016\/j.pcd.2020.08.002","journal-title":"Prim Care Diabetes"},{"key":"1466_CR83","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.diabres.2016.03.007","volume":"115","author":"X Guo","year":"2016","unstructured":"Guo X, Meng G, Liu F et al (2016) Serum levels of immunoglobulins in an adult population and their relationship with type 2 diabetes. Diabetes Res Clin Pract 115:76\u201382. https:\/\/doi.org\/10.1016\/j.diabres.2016.03.007","journal-title":"Diabetes Res Clin Pract"},{"key":"1466_CR84","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/cei.12148","volume":"174","author":"K Jennbacken","year":"2013","unstructured":"Jennbacken K, St\u00e5hlman S, Grahnemo L et al (2013) Glucose impairs B-1 cell function in diabetes. Clin Exp Immunol 174:129\u2013138. https:\/\/doi.org\/10.1111\/cei.12148","journal-title":"Clin Exp Immunol"},{"key":"1466_CR85","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1055\/s-2002-32140","volume":"34","author":"A Lapolla","year":"2002","unstructured":"Lapolla A, Tonani R, Fedele D et al (2002) Non-enzymatic glycation of IgG: an in vivo study. Horm Metab Res 34:260\u2013264. https:\/\/doi.org\/10.1055\/s-2002-32140","journal-title":"Horm Metab Res"},{"key":"1466_CR86","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ab.2010.08.038","volume":"408","author":"PK Pampati","year":"2011","unstructured":"Pampati PK, Suravajjala S, Dain JA (2011) Monitoring nonenzymatic glycation of human immunoglobulin G by methylglyoxal and glyoxal: a spectroscopic study. Anal Biochem 408:59\u201363. https:\/\/doi.org\/10.1016\/j.ab.2010.08.038","journal-title":"Anal Biochem"},{"key":"1466_CR87","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1177\/147323001003800218","volume":"38","author":"H Fang","year":"2010","unstructured":"Fang H, Yang J (2010) Tissue-specific pattern of angiotensin-converting enzyme 2 expression in rat pancreas. J Int Med Res 38:558\u2013569. https:\/\/doi.org\/10.1177\/147323001003800218","journal-title":"J Int Med Res"},{"key":"1466_CR88","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.mce.2008.09.020","volume":"302","author":"SM Bindom","year":"2009","unstructured":"Bindom SM, Lazartigues E (2009) The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol 302:193\u2013202. https:\/\/doi.org\/10.1016\/j.mce.2008.09.020","journal-title":"Mol Cell Endocrinol"},{"key":"1466_CR89","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","volume":"47","author":"J-K Yang","year":"2010","unstructured":"Yang J-K, Lin S-S, Ji X-J, Guo L-M (2010) Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 47:193\u2013199. https:\/\/doi.org\/10.1007\/s00592-009-0109-4","journal-title":"Acta Diabetol"},{"key":"1466_CR90","doi-asserted-by":"crossref","unstructured":"Jia X, Yin C, Lu S et al (2020) Two things about COVID-19 might need attention. Medicine & Pharmacology","DOI":"10.20944\/preprints202002.0315.v1"},{"key":"1466_CR91","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","volume":"26","author":"SE Geerlings","year":"1999","unstructured":"Geerlings SE, Hoepelman AIM (1999) Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26:259\u2013265. https:\/\/doi.org\/10.1111\/j.1574-695X.1999.tb01397.x","journal-title":"FEMS Immunol Med Microbiol"},{"key":"1466_CR92","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.arteri.2020.10.001","volume":"33","author":"MM Lima-Mart\u00ednez","year":"2021","unstructured":"Lima-Mart\u00ednez MM, Carrera Boada C, Madera-Silva MD et al (2021) COVID-19 y diabetes mellitus: una relaci\u00f3n bidireccional. Cl\u00ednica E Investigaci\u00f3n en Arterioscler 33:151\u2013157. https:\/\/doi.org\/10.1016\/j.arteri.2020.10.001","journal-title":"Cl\u00ednica E Investigaci\u00f3n en Arterioscler"},{"key":"1466_CR93","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1210\/clinem\/dgaa874","volume":"106","author":"C Edwards","year":"2021","unstructured":"Edwards C (2021) New horizons: does mineralocorticoid receptor activation by cortisol cause ATP release and COVID-19 complications? J Clin Endocrinol Metabolism 106:622\u2013635. https:\/\/doi.org\/10.1210\/clinem\/dgaa874","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1466_CR94","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3390\/ijms18051032","volume":"18","author":"J Funder","year":"2017","unstructured":"Funder J (2017) Aldosterone and mineralocorticoid receptors\u2014physiology and pathophysiology. IJMS 18:1032. https:\/\/doi.org\/10.3390\/ijms18051032","journal-title":"IJMS"},{"key":"1466_CR95","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1158\/2159-8290.CD-20-0451","volume":"10","author":"KH Stopsack","year":"2020","unstructured":"Stopsack KH, Mucci LA, Antonarakis ES et al (2020) TMPRSS2 and COVID-19: serendipity or opportunity for intervention? Cancer Discov 10:779\u2013782. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0451","journal-title":"Cancer Discov"},{"key":"1466_CR96","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Van Der Kruip MJHA et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145\u2013147. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.013","journal-title":"Thromb Res"},{"key":"1466_CR97","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1111\/jth.14849","volume":"18","author":"JM Connors","year":"2020","unstructured":"Connors JM, Levy JH (2020) Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost 18:1559\u20131561. https:\/\/doi.org\/10.1111\/jth.14849","journal-title":"J Thromb Haemost"},{"key":"1466_CR98","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000314349","volume":"92","author":"L Trementino","year":"2010","unstructured":"Trementino L, Arnaldi G, Appolloni G et al (2010) Coagulopathy in Cushing\u2019s syndrome. Neuroendocrinology 92:55\u201359. https:\/\/doi.org\/10.1159\/000314349","journal-title":"Neuroendocrinology"},{"key":"1466_CR99","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1080\/17474086.2020.1831383","volume":"13","author":"M Rostami","year":"2020","unstructured":"Rostami M, Mansouritorghabeh H (2020) D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol 13:1265\u20131275. https:\/\/doi.org\/10.1080\/17474086.2020.1831383","journal-title":"Expert Rev Hematol"},{"key":"1466_CR100","doi-asserted-by":"publisher","first-page":"e0272216","DOI":"10.1371\/journal.pone.0272216","volume":"17","author":"E Tekle","year":"2022","unstructured":"Tekle E, Gelaw Y, Dagnew M et al (2022) Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients. PLoS ONE 17:e0272216. https:\/\/doi.org\/10.1371\/journal.pone.0272216","journal-title":"PLoS ONE"},{"key":"1466_CR101","doi-asserted-by":"publisher","unstructured":"The, RECOVERY Collaborative Group (2021) Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384:693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436","DOI":"10.1056\/NEJMoa2021436"},{"key":"1466_CR102","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2020.17023","volume":"324","author":"JAC Sterne","year":"2020","unstructured":"The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JAC, Murthy S et al (2020) Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 324:1330. https:\/\/doi.org\/10.1001\/jama.2020.17023","journal-title":"JAMA"},{"key":"1466_CR103","doi-asserted-by":"publisher","first-page":"578","DOI":"10.4049\/jimmunol.179.1.578","volume":"179","author":"N Zhang","year":"2007","unstructured":"Zhang N, Truong-Tran QA, Tancowny B et al (2007) Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT\/enhancer binding proteins. J Immunol 179:578\u2013589. https:\/\/doi.org\/10.4049\/jimmunol.179.1.578","journal-title":"J Immunol"},{"key":"1466_CR104","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5603\/EP.a2023.0041","volume":"74","author":"A Bogus\u0142awska","year":"2023","unstructured":"Bogus\u0142awska A, Minasyan M, Hubalewska-Dydejczyk A, Gilis-Januszewska A (2023) COVID-19 infection in a patient with Cushing\u2019s disease on osilodrostat treatment. Endokrynol Pol 74:342\u2013343. https:\/\/doi.org\/10.5603\/EP.a2023.0041","journal-title":"Endokrynol Pol"},{"key":"1466_CR105","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3389\/fendo.2020.00554","volume":"11","author":"F Beretta","year":"2020","unstructured":"Beretta F, Dassie F, Parolin M et al (2020) Practical considerations for the management of Cushing\u2019s disease and COVID-19: a case report. Front Endocrinol 11:554. https:\/\/doi.org\/10.3389\/fendo.2020.00554","journal-title":"Front Endocrinol"},{"key":"1466_CR106","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s11102-022-01268-2","volume":"25","author":"M Fleseriu","year":"2022","unstructured":"Fleseriu M, Biller BMK (2022) Treatment of Cushing\u2019s syndrome with osilodrostat: practical applications of recent studies with case examples. Pituitary 25:795\u2013809. https:\/\/doi.org\/10.1007\/s11102-022-01268-2","journal-title":"Pituitary"},{"key":"1466_CR107","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s11102-022-01261-9","volume":"25","author":"RA Feelders","year":"2022","unstructured":"Feelders RA, Nieman LK (2022) Hypercoagulability in Cushing\u2019s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols. Pituitary 25:746\u2013749. https:\/\/doi.org\/10.1007\/s11102-022-01261-9","journal-title":"Pituitary"},{"key":"1466_CR108","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.2337\/dc20-1521","volume":"43","author":"SB Solerte","year":"2020","unstructured":"Solerte SB, D\u2019Addio F, Trevisan R et al (2020) Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control, retrospective, observational study. Diabetes Care 43:2999\u20133006. https:\/\/doi.org\/10.2337\/dc20-1521","journal-title":"Diabetes Care"},{"key":"1466_CR109","doi-asserted-by":"publisher","first-page":"108125","DOI":"10.1016\/j.diabres.2020.108125","volume":"162","author":"G Iacobellis","year":"2020","unstructured":"Iacobellis G (2020) COVID-19 and diabetes: can DPP4 inhibition play a role? Diabetes Res Clin Pract 162:108125. https:\/\/doi.org\/10.1016\/j.diabres.2020.108125","journal-title":"Diabetes Res Clin Pract"},{"key":"1466_CR110","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"CM Ferrario","year":"2005","unstructured":"Ferrario CM, Jessup J, Chappell MC et al (2005) Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111:2605\u20132610. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.510461","journal-title":"Circulation"},{"key":"1466_CR111","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","volume":"382","author":"G Mancia","year":"2020","unstructured":"Mancia G, Rea F, Ludergnani M et al (2020) Renin\u2013angiotensin\u2013aldosterone system blockers and the risk of Covid-19. N Engl J Med 382:2431\u20132440. https:\/\/doi.org\/10.1056\/NEJMoa2006923","journal-title":"N Engl J Med"},{"key":"1466_CR112","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1056\/NEJMe2012924","volume":"382","author":"JA Jarcho","year":"2020","unstructured":"Jarcho JA, Ingelfinger JR, Hamel MB et al (2020) Inhibitors of the renin\u2013angiotensin\u2013aldosterone system and Covid-19. N Engl J Med 382:2462\u20132464. https:\/\/doi.org\/10.1056\/NEJMe2012924","journal-title":"N Engl J Med"},{"key":"1466_CR113","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","volume":"126","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhu L, Cai J et al (2020) Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circul Res 126:1671\u20131681. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317134","journal-title":"Circul Res"},{"key":"1466_CR114","unstructured":"Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician. In: American Heart Association. https:\/\/newsroom.heart.org\/news\/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician. Accessed 19 Mar 2024"},{"key":"1466_CR115","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1016\/j.vaccine.2013.05.004","volume":"31","author":"N Y\u0131ld\u0131z","year":"2013","unstructured":"Y\u0131ld\u0131z N, Sever L, Kasap\u00e7opur \u00d6 et al (2013) Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: immunogenicity and safety? Vaccine 31:3309\u20133312. https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.004","journal-title":"Vaccine"},{"key":"1466_CR116","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1634\/theoncologist.2011-0342","volume":"17","author":"AF Hottinger","year":"2012","unstructured":"Hottinger AF, George A-CC, Bel M et al (2012) A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A\/H1N1 vaccine in cancer outpatients. Oncologist 17:436\u2013445. https:\/\/doi.org\/10.1634\/theoncologist.2011-0342","journal-title":"Oncologist"},{"key":"1466_CR117","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1001\/jama.1979.03300010037025","volume":"242","author":"A Herron","year":"1979","unstructured":"Herron A (1979) Influenza vaccination in patients with rheumatic diseases: safety and efficacy. JAMA 242:53. https:\/\/doi.org\/10.1001\/jama.1979.03300010037025","journal-title":"JAMA"},{"key":"1466_CR118","doi-asserted-by":"publisher","first-page":"SI180","DOI":"10.1093\/rheumatology\/keac089","volume":"61","author":"M Krasselt","year":"2022","unstructured":"Krasselt M, Wagner U, Nguyen P et al (2022) Humoral and cellular response to COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases under real-life conditions. Rheumatology 61:SI180\u2013SI188. https:\/\/doi.org\/10.1093\/rheumatology\/keac089","journal-title":"Rheumatology"},{"key":"1466_CR119","doi-asserted-by":"publisher","first-page":"889928","DOI":"10.3389\/fendo.2022.889928","volume":"13","author":"B Popovic","year":"2022","unstructured":"Popovic B, Radovanovic Spurnic A, Velickovic J et al (2022) Successful immunomodulatory treatment of COVID-19 in a patient with severe ACTH-dependent Cushing\u2019s syndrome: a case report and review of literature. Front Endocrinol 13:889928. https:\/\/doi.org\/10.3389\/fendo.2022.889928","journal-title":"Front Endocrinol"},{"key":"1466_CR120","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.dsx.2020.06.042","volume":"14","author":"YV Chudasama","year":"2020","unstructured":"Chudasama YV, Gillies CL, Zaccardi F et al (2020) Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals. Diabetes Metabolic Syndrome: Clin Res Reviews 14:965\u2013967. https:\/\/doi.org\/10.1016\/j.dsx.2020.06.042","journal-title":"Diabetes Metabolic Syndrome: Clin Res Reviews"},{"key":"1466_CR121","doi-asserted-by":"publisher","unstructured":"Bozkur E, Turgut S, Pamuk N et al (2022) The effect of COVID-19 process on patients with endocrinological disease in a pandemic hospital: what happened to the others? Archives of Endocrinology and Metabolism. https:\/\/doi.org\/10.20945\/2359-3997000000525","DOI":"10.20945\/2359-3997000000525"},{"key":"1466_CR122","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1055\/a-2187-3547","volume":"55","author":"C Chiapponi","year":"2023","unstructured":"Chiapponi C, Faust M, Schmidt M et al (2023) The impact of the COVID pandemic on adrenal surgery at an academic endocrine surgery unit. Horm Metab Res 55:765\u2013770. https:\/\/doi.org\/10.1055\/a-2187-3547","journal-title":"Horm Metab Res"},{"key":"1466_CR123","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s11154-020-09598-x","volume":"22","author":"V Guarnotta","year":"2021","unstructured":"Guarnotta V, Ferrigno R, Martino M et al (2021) Glucocorticoid excess and COVID-19 disease. Rev Endocr Metab Disord 22:703\u2013714. https:\/\/doi.org\/10.1007\/s11154-020-09598-x","journal-title":"Rev Endocr Metab Disord"},{"key":"1466_CR124","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11102-020-01059-7","volume":"23","author":"M Fleseriu","year":"2020","unstructured":"Fleseriu M, Buchfelder M, Cetas JS et al (2020) Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic\u2014an international perspective. Pituitary 23:327\u2013337. https:\/\/doi.org\/10.1007\/s11102-020-01059-7","journal-title":"Pituitary"},{"key":"1466_CR125","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s40618-020-01476-2","volume":"44","author":"F Ceccato","year":"2021","unstructured":"Ceccato F, Voltan G, Sabbadin C et al (2021) Tele-medicine versus face-to-face consultation in endocrine outpatients clinic during COVID-19 outbreak: a single-center experience during the lockdown period. J Endocrinol Invest 44:1689\u20131698. https:\/\/doi.org\/10.1007\/s40618-020-01476-2","journal-title":"J Endocrinol Invest"},{"key":"1466_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1539203","volume":"2022","author":"B Zampetti","year":"2022","unstructured":"Zampetti B, Attanasio R, Carioni E et al (2022) A tale of two hypersecreting adrenal neoplasms in the heartland of COVID-19 pandemic, Lombardy, Italy. Case Rep Endocrinol 2022:1\u20134. https:\/\/doi.org\/10.1155\/2022\/1539203","journal-title":"Case Rep Endocrinol"},{"key":"1466_CR127","doi-asserted-by":"publisher","unstructured":"Amodru V, Brue T, Castinetti F (2021) Synergistic cortisol suppression by ketoconazole\u2013osilodrostat combination therapy. Endocrinology, Diabetes & Metabolism Case Reports 2021. https:\/\/doi.org\/10.1530\/EDM-21-0071","DOI":"10.1530\/EDM-21-0071"},{"key":"1466_CR128","doi-asserted-by":"publisher","unstructured":"Faisal Z, Debono M (2021) Rapid control of ectopic Cushing\u2019s syndrome during the COVID-19 pandemic in a patient with chronic hypokalaemia. Endocrinology, Diabetes & Metabolism Case Reports 2021. https:\/\/doi.org\/10.1530\/EDM-21-0038","DOI":"10.1530\/EDM-21-0038"},{"key":"1466_CR129","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.dsx.2020.05.050","volume":"14","author":"R Pal","year":"2020","unstructured":"Pal R, Bhadada SK (2020) Managing common endocrine disorders amid COVID-19 pandemic. Diabetes Metabolic Syndrome: Clin Res Reviews 14:767\u2013771. https:\/\/doi.org\/10.1016\/j.dsx.2020.05.050","journal-title":"Diabetes Metabolic Syndrome: Clin Res Reviews"},{"key":"1466_CR130","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0090-3019(02)01037-6","volume":"59","author":"R Reisch","year":"2003","unstructured":"Reisch R, Perneczky A, Filippi R (2003) Surgical technique of the supraorbital key-hole craniotomy. Surg Neurol 59:223\u2013227. https:\/\/doi.org\/10.1016\/S0090-3019(02)01037-6","journal-title":"Surg Neurol"},{"key":"1466_CR131","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1055\/s-0041-1730352","volume":"83","author":"M Amarouche","year":"2022","unstructured":"Amarouche M, Rashid S, Eraifej J et al (2022) Safety of endoscopic transsphenoidal pituitary surgery during the COVID-19 pandemic and comparison to the pre-pandemic era. J Neurol Surg B Skull Base 83:e419\u2013e429. https:\/\/doi.org\/10.1055\/s-0041-1730352","journal-title":"J Neurol Surg B Skull Base"},{"key":"1466_CR132","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1055\/s-0041-1742104","volume":"83","author":"C Taneja","year":"2022","unstructured":"Taneja C, Fazeli PK, Gardner PA et al (2022) Rapidly progressive pituitary apoplexy in a patient with COVID-19 disease treated with endoscopic endonasal surgery. J Neurol Surg Rep 83:e8\u2013e12. https:\/\/doi.org\/10.1055\/s-0041-1742104","journal-title":"J Neurol Surg Rep"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01466-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01466-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01466-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T05:38:51Z","timestamp":1733895531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01466-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":132,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1466"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01466-0","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"15 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JB has received grants to his institution from Neurocrine, HRA Pharma, and Recordati, and personal honoraria for consulting, lectures, and\/or meeting attendance from HRA Pharma, Corcept and Recordati.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}